ArticleMDM policy & practice

Evaluating the Benefits of New Drugs in Health Technology Assessment Using Multiple Criteria Decision Analysis: A Case Study on Metastatic Prostate Cancer With the Dental and Pharmaceuticals Benefits Agency (TLV) in Sweden.

Aris AngelisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.